Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|June 12, 2021
Synthesis and Characterization of Mitochondria-Targeted Triphenylphosphonium BolaamphiphilesFrancesca Ceccacci, Simona Sennato, Edoardo Rossi, et al.
Journal of Colloid and Interface Science|July 28, 2018
Aggregation behaviour of triphenylphosphonium bolaamphiphilesFrancesca Ceccacci, Simona Sennato, Edoardo Rossi, et al.
Journal of Medicinal Chemistry|July 22, 2005
Inclusion of a photosensitizer in liposomes formed by DMPC/gemini surfactant: correlation between physicochemical and biological features of the complexesCecilia Bombelli, Giulio Caracciolo, Pietro Di Profio, et al.
Chemistry and Physics of Lipids|January 17, 2022
Resveratrol loaded in cationic glucosylated liposomes to treat Staphylococcus epidermidis infectionsLivia Pagano, Foteini Gkartziou, Stefano Aiello, et al.
Pharmaceutics|June 27, 2025
Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T <i>PTPN22</i> Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine AutoimmunitySimona Sennato, Giorgia Paldino, Cecilia Bombelli, et al.
International Journal of Nanomedicine|April 2, 2026
Triphenylphosphonium Bolaamphiphile-Liposomes Loaded with Resveratrol and Trolox: Mitochondriotropic Formulations with Therapeutic Potential in Neurodegeneration and CancerFrancesca Ceccacci, Fabrizio Ciranna, Simona Sennato, et al.
Molecules (Basel, Switzerland)|July 12, 2025
Novel Azole-Modified Porphyrins for Mitochondria-Targeted Photodynamic TherapySabarinathan Rangasamy, Elisa Bandini, Alessandro Venturini, et al.
Colloids and Surfaces. B, Biointerfaces|June 17, 2026
Liposome formulation of a myristoylated antimicrobial peptide derived from Chionodracine: preparation, physico-chemical characterization and biological activityFederica Toma, Antonia Volpe, Fabiana Pandolfi, et al.
Pharmaceutics|December 31, 2025
Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T <i>PTPN22</i> Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. <i>Pharmaceutics</i> 2025, <i>17</i>, 710Simona Sennato, Giorgia Paldino, Cecilia Bombelli, et al.
International Journal of Molecular Sciences|February 26, 2022
Design and Characterization of Myristoylated and Non-Myristoylated Peptides Effective against <i>Candida</i> spp. Clinical IsolatesFrancesca Bugli, Federica Massaro, Francesco Buonocore, et al.
Pageof 5